GlaxoSmithKline Taking Steps To Help Reduce Drug Prices In Lower-Income Countries

The Guardian: GlaxoSmithKline to lower drug prices in poorer countries
“GlaxoSmithKline is taking action to make medicines more affordable in developing countries, including waiving patent protection for new drugs in the world’s poorest nations. … The measures will affect 85 countries, helping more than two billion people, and benefit Africa most, according to GSK. Any GSK medicines on the World Health Organization’s list of essential medicines will be automatically included…” (Kollewe, 3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.